These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


298 related items for PubMed ID: 6336708

  • 21. Efficacy of bicozamycin in preventing traveler's diarrhea.
    Ericsson CD, DuPont HL, Galindo E, Mathewson JJ, Morgan DR, Wood LV, Mendiola J.
    Gastroenterology; 1985 Feb; 88(2):473-7. PubMed ID: 3965336
    [Abstract] [Full Text] [Related]

  • 22. Looking for evidence that personal hygiene precautions prevent traveler's diarrhea.
    Shlim DR.
    Clin Infect Dis; 2005 Dec 01; 41 Suppl 8():S531-5. PubMed ID: 16267714
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen.
    Tribble DR, Sanders JW, Pang LW, Mason C, Pitarangsi C, Baqar S, Armstrong A, Hshieh P, Fox A, Maley EA, Lebron C, Faix DJ, Lawler JV, Nayak G, Lewis M, Bodhidatta L, Scott DA.
    Clin Infect Dis; 2007 Feb 01; 44(3):338-46. PubMed ID: 17205438
    [Abstract] [Full Text] [Related]

  • 25. Antimicrobial prophylaxis of travellers' diarrhoea: a summary of studies using doxycycline or trimethoprim and sulphamethoxazole.
    Sack RB.
    Scand J Gastroenterol Suppl; 1983 Feb 01; 84():111-7. PubMed ID: 6356325
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Traveler's diarrhea. Incidence--pathogens--pathophysiology--clinical aspects--prevention and therapy].
    Leiss O.
    Leber Magen Darm; 1991 Jun 01; 21(4):148-52. PubMed ID: 1943430
    [Abstract] [Full Text] [Related]

  • 30. Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of traveler's diarrhea: a randomized, double-blind, controlled study.
    Briand V, Buffet P, Genty S, Lacombe K, Godineau N, Salomon J, Vandemelbrouck E, Ralaimazava P, Goujon C, Matheron S, Fontanet A, Bouchaud O.
    Clin Infect Dis; 2006 Nov 01; 43(9):1170-5. PubMed ID: 17029137
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Prevention of traveler's diarrhea.
    Graham DY.
    JAMA; 1985 Nov 08; 254(18):2559. PubMed ID: 3903231
    [No Abstract] [Full Text] [Related]

  • 33. Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximin.
    DuPont HL, Jiang ZD, Okhuysen PC, Ericsson CD, de la Cabada FJ, Ke S, DuPont MW, Martinez-Sandoval F.
    Clin Infect Dis; 2005 Dec 01; 41 Suppl 8():S571-6. PubMed ID: 16267721
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Travel medicine 2005.
    Juckett G.
    W V Med J; 2004 Dec 01; 100(6):222-5. PubMed ID: 15777061
    [Abstract] [Full Text] [Related]

  • 36. Prevalence of Escherichia coli possessing the eaeA gene of enteropathogenic E. coli (EPEC) or the aggR gene of enteroaggregative E. coli (EAggEC) in traveler's diarrhea diagnosed in those returning to Tama, Tokyo from other Asian countries.
    Ogata K, Kato R, Ito K, Yamada S.
    Jpn J Infect Dis; 2002 Feb 01; 55(1):14-8. PubMed ID: 11971156
    [Abstract] [Full Text] [Related]

  • 37. Sequelae of traveler's diarrhea: focus on postinfectious irritable bowel syndrome.
    Connor BA.
    Clin Infect Dis; 2005 Dec 01; 41 Suppl 8():S577-86. PubMed ID: 16267722
    [Abstract] [Full Text] [Related]

  • 38. Doxycycline and the traveller.
    Merson MH.
    Gastroenterology; 1979 Jun 01; 76(6):1485-8. PubMed ID: 374179
    [No Abstract] [Full Text] [Related]

  • 39. A randomized, double-blind study to assess the optimal duration of doxycycline treatment for human brucellosis.
    Solera J, Geijo P, Largo J, Rodriguez-Zapata M, Gijón J, Martinez-Alfaro E, Navarro E, Macia MA, Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.
    Clin Infect Dis; 2004 Dec 15; 39(12):1776-82. PubMed ID: 15578399
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.